The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 359:200-202 July 10, 2008 Number 2
NextNext

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Sanda, M. G.
-PubMed Citation
To the Editor: The quality of life is an important consideration in treatment for prostate cancer. The study by Sanda et al. (March 20 issue)1 provides valuable information regarding this aspect of treatment. Unfortunately, the abstract highlights two of the least relevant observations made in this study. First, although the authors show that hormone therapy diminishes the quality of life, class I evidence supports its use in intermediate-risk and high-risk patients receiving radiotherapy.2,3,4,5 Highlighting a small effect on the quality of life, given the survival advantages, seems inappropriate. Second, the decision to offer nerve-sparing radical prostatectomy is usually dictated more . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.